Search Results - "Iasella, C.J"

Systematic Review and Meta-Analysis of Death After Posttransplant Lymphoproliferative Disease in Lung Transplantation by Moore, C.A, Cheng, J, Iasella, C.J, Glanville, A.R, Morrell, M.R, Smith, R.B, Hayanga, J, McDyer, J.F, Ensor, C.R

Get full text

Increasing Tacrolimus Time-in-Therapeutic Range Is Associated with Reduced Chronic Lung Allograft Dysfunction by Moore, C.A, Harrigan, K.M, Iasella, C.J, Venkataramanan, R, Morrell, M.R, Hayanga, J, D'Cunha, J, Zeevi, A, McDyer, J, Ensor, C.R

Get full text

Successful Maintenance Belatacept-Based Immunosuppression in Lung Transplantation Recipients Who Failed Calcineurin Inhibitors by Iasella, C.J, Winstead, R.J, Moore, C.A, Johnson, B.A, Morrell, M.R, Hayanga, J, Zeevi, A, Lendermon, E.A, McDyer, J.F, Ensor, C.R

Get full text

(1165) Safety and Effectiveness of Extended Duration Cytomegalovirus Prophylaxis in High-Risk Lung Transplant Recipients: A Retrospective Cohort Study by Iasella, C.J., Smith, A., Sacha, L., Zhuang, M., Sanchez, P., Hage, C., McDyer, J., Moore, C.A.

“…There is limited data to support cytomegalovirus (CMV) prophylaxis beyond 12 months in lung transplant patients. We retrospectively assessed outcomes of 12…”
Get full text

Rabbit Anti-Thymocyte Globulin for Treatment of Corticosteroid Refractory Acute Cellular Rejection After Lung Transplantation by Rudzik, K.N., Moore, C.A., Sacha, L.M., Rivosecchi, R.M., Pilewski, J.M., Kilaru, S.D., McDyer, J.F., Iasella, C.J.

“…Chronic Lung Allograft Dysfunction (CLAD) is the major cause of graft failure and death after the first-year post-transplant. Acute Cellular Rejection (ACR) of…”
Get full text

Effectiveness and Safety of Direct Oral Anticoagulants versus Warfarin in Lung Transplant Recipients by Iasella, C.J., Moore, C.A., Rivosecchi, R., Sacha, L., Morrell, M.R., Sanchez, P.G., McDyer, J.F., Coons, J.C.

“…Lung transplant recipients (LTRs) are at an increased risk for venous thromboembolism (VTE) after transplant, necessitating the use of anticoagulation…”
Get full text

(1142) - Early Acute Cellular Rejection in Lung Transplant Recipients is Associated with Greater Variation in the Lung Allograft Microbiome by Iasella, C.J., Ensor, C.R., Morris, A., Methé, B., McDyer, J.F.

Get full text

(406) - Pre-Transplant Opioid Use is Associated with Increased Early Mortality and Readmission after Lung Transplantation by Heiney, H., Iasella, C.J., Moore, C.A., Venkataramanan, R., Morrell, M.R., Hayanga, J., Shigemura, N., Zeevi, A., McDyer, J.F., Ensor, C.R.

Get full text

(210) - Effect of Everolimus and CNI Reduction on Rejection, CLAD, and Death in Thoracic Transplant Recipients by Cartus, R.A., Iasella, C.J., Moore, C.A., Morrell, M.R., Hayanga, J., Shigemura, N., Zeevi, A., McDyer, J.F., Ensor, C.R.

Get full text

(629) - Prevalence and Treatment Responsiveness of Lung Transplant Recipients with Post Transplant Lymphoproliferative Disease by Berger, O., Iasella, C.J., Moore, C.A., Morrell, M.R., Hayanga, J., Shigemura, N., Zeevi, A., McDyer, J.F., Ensor, C.R.

Get full text

(1264) - Impact of Right Ventricular Function and Pulmonary Hypertension Therapy on Graft Dysfunction and Death in Lung Transplant Recipients by Thornberg, M., Iasella, C.J., Esper, S.A., Moore, C.A., Morrell, M.R., Hayanga, J., Shigemura, N., Zeevi, A., McDyer, J.F., Ensor, C.R.

Get full text

Increased Hazard of Chronic Lung Allograft Dysfunction in the Presence of Persistent and Complement Fixing Donor-Specific Antibodies by Iasella, C.J., Ensor, C.R., Marrari, M., Mangiola, M., Moore, C.A., Morrell, M.R., Pilewski, J.M., D'Cunha, J., Sanchez, P., McDyer, J.F., Zeevi, A.

“…Long-term survival in lung transplant recipients (LTR) is limited in large part due to chronic lung allograft dysfunction (CLAD). Donor-specific antibodies…”
Get full text

Airway Transcriptome Analysis and Immune Proteome Profiling of the Lung Allograft Reveals Novel Immune Signatures in Chronic Lung Allograft Dysfunction by Iasella, C.J., Hoji, A., Zhang, Y., Xu, W., Chen, K., Brown, M., Lendermon, E., Johnson, B.A., Kilaru, S., Morrell, M.R., Pilewski, J.M., McDyer, J.F.

“…Chronic lung allograft dysfunction (CLAD) is the major limitation to long-term survival in lung transplant recipients (LTRs). The underlying biologic…”
Get full text

Transcriptome Analysis of Airway Brushes in Lung Transplant Recipients with and without Chronic Lung Allograft Dysfunction by Iasella, C.J., Snyder, M., Popescu, I., Wei, J., Hoji, A., Zhang, Y., Xu, W., Iouchmanov, V., Brown, M., Lendermon, E., Johnson, B., Kilaru, S., Morrell, M., Pilewski, J., Greenland, J., Chen, K., McDyer, J.F.

“…Chronic lung allograft dysfunction (CLAD) in lung transplant recipients (LTRs) limits long-term survival compared to other solid organ transplants. Underlying…”
Get full text

Idiopathic Pulmonary Fibrosis Lung Transplant Recipients are at Increased Risk for Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disorder by Iasella, C.J., Winters, S., Kois, A., Cho, J., Hannan, S.J., Koshy, R., Moore, C., Lendermon, E.A., Pilewski, J., Morrell, M., Sanchez, P.G., Kass, D., Alder, J.K., Nouriea, S.M., McDyer, J.

“…Epstein-Barr virus (EBV)-associated post-transplant lymphoproliferative disorder (PTLD) is a serious complication in lung transplant recipients (LTRs)…”
Get full text